title: Utility of a transdermal delivery system for antihypertensive therapy. Part 2.
authors.forename: D A
authors.initials: DA
authors.lastname: Sclar
authors.forename: T L
authors.initials: TL
authors.lastname: Skaer
authors.forename: A
authors.initials: A
authors.lastname: Chin
authors.forename: M P
authors.initials: MP
authors.lastname: Okamoto
authors.forename: M A
authors.initials: MA
authors.lastname: Gill
mesh_terms: D000279:Administration, Cutaneous; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003000:Clonidine / Q000008:administration & dosage* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D011307:Drug Prescriptions / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics / Q000523:psychology; D008484:Medicaid / Q000191:economics*; D010349:Patient Compliance; D012189:Retrospective Studies; D013022:South Carolina; D014481:United States
chemical_list: D000959:Antihypertensive Agents; D003000:Clonidine